Similarly, the FGFR1 and FGFR3 dual inhibitor PD173074 blocked cell cycle progression and caused apoptosis in lung, head and neck, breast, and urothelial carcinoma cells [11,13,14,15]. Here, FGFR1 is linked to urothelial carcinoma.